Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

BioSyent

Tracked across 2 events · 14 articles · First seen Feb 09, 2026 · Last active Mar 24, 2026

Sentiment
35
Attention
4
Events
2
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 70
Business
BioSyent successfully closed the acquisition of BioSyent===Oral Science for $25.5 million, expanding its oral health business unit. This acquisition is expected to contribute to BioSyent's growth and profitability.
Feb 09, 2026 · 7 articles
2 0
Business
BioSyent is announcing its financial results for the fourth quarter and full year ended December 31, 2025. This event is a routine financial disclosure for BioSyent, providing transparency to investors regarding its performance.
Mar 12, 2026 · 7 articles
René C. Goehrum President and CEO BioSyent René C. Goehrum is the President and CEO of BioSyent.
BioSyent===Oral Science acquirer BioSyent BioSyent acquired BioSyent===Oral Science to expand its oral health business uni
René Goehrum President and CEO BioSyent René Goehrum is the President and CEO of BioSyent.
Royal Bank of Canada lender BioSyent Royal Bank of Canada provided financing for BioSyent's acquisition.
NEWSDESK
Track BioSyent live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.